A Phase II Study of the Combination of Azacitidine and Pembrolizumab for Patients Relapsed/Refractory Hodgkin's Lymphoma

Abroad (travel likely)RecruitingPHASE2

Conditions

Hodgkin's Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

MD Anderson Cancer Center, Houston, Texas, United States
Contact: Study coordinator (David McCall, MD) · dmccall1@mdanderson.org · 713-792-6604
Contact: Principal Investigator (David McCall, MD)

Study leads

David McCall, MD
Principal Investigator
M.D. Anderson Cancer Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Clinical Study of U16 in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Relapsed or Refractory Non-Hodgkin's Lymphoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Changsha, China · Suzhou, China

Human CD19 Targeted T Cells Injection(CD19 CAR-T) Therapy for Relapsed and Refractory B-cell Non-Hodgkin's Lymphoma

B-cell Non-Hodgkin's Lymphoma

Abroad (travel likely)RecruitingPHASE2

Shanghai, China

EBV Specific T-Lymphocytes for Treatment of EBV-Positive Lymphoma

EBV-Related Hodgkin Lymphoma · EBV-Related Lymphoproliferative Disorder · EBV Related Non-Hodgkin's Lymphoma

Abroad (travel likely)RecruitingPHASE1

Houston, United States · Houston, United States

GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, Treatment and Outcome of Adult Acute Lymphoblastic Leukemia (ALL) Patients and Related Diseases Associated With a Prospective Collection of Biomaterial

Acute Lymphoblastic Leukemia · Leukemia · Non-Hodgkin's Lymphoma

Abroad (travel likely)Recruiting

Graz, Austria · Leoben, Austria